Pharmacokinetic and Pharmacodynamic Considerations When Treating Patients with Sepsis and Septic Shock
- 1 January 2002
- journal article
- review article
- Published by Springer Nature in Clinical Pharmacokinetics
- Vol. 41 (14), 1135-1151
- https://doi.org/10.2165/00003088-200241140-00002
Abstract
Sepsis and septic shock are accompanied by profound changes in the organism that may alter both the pharmacokinetics and the pharmacodynamics of drugs. This review elaborates on the mechanisms by...Keywords
This publication has 131 references indexed in Scilit:
- Adjunctive Drug Treatment in Severe Hypoxic Respiratory FailureDrugs, 1999
- Pharmacokinetic Optimisation of the Treatment of Bacterial Central Nervous System InfectionsClinical Pharmacokinetics, 1998
- Pharmacokinetics of Drugs Used in Critically Ill AdultsClinical Pharmacokinetics, 1998
- Protecting the gut and the liver in the critically illCritical Care Medicine, 1994
- Adequacy of gut oxygenation in endotoxemia and sepsisCritical Care Medicine, 1993
- Impaired β-adrenergic receptor stimulation of cyclic adenosine monophosphate in human septic shockCritical Care Medicine, 1993
- American College of Chest Physicians/Society of Critical Care Medicine Consensus ConferenceCritical Care Medicine, 1992
- The Altered Pharmacokinetics and Pharmacodynamics of Drugs Commonly Used in Critically III PatientsClinical Pharmacokinetics, 1988
- Influence of Positive End-Expiratory Pressure on Left Ventricular PerformanceNew England Journal of Medicine, 1981
- Interrelationship Between Renal Haemodynamics, Drug Kinetics and Drug ActionClinical Pharmacokinetics, 1978